126 related articles for article (PubMed ID: 12781632)
1. Parenteral N,N-diethyldithiocarbamate produces segmental demyelination in the rat that is not dependent on cysteine carbamylation.
Tonkin EG; Valentine HL; Zimmerman LJ; Valentine WM
Toxicol Appl Pharmacol; 2003 Jun; 189(2):139-50. PubMed ID: 12781632
[TBL] [Abstract][Full Text] [Related]
2. N,N-diethyldithiocarbamate produces copper accumulation, lipid peroxidation, and myelin injury in rat peripheral nerve.
Tonkin EG; Valentine HL; Milatovic DM; Valentine WM
Toxicol Sci; 2004 Sep; 81(1):160-71. PubMed ID: 15187237
[TBL] [Abstract][Full Text] [Related]
3. Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate.
Valentine HL; Amarnath K; Amarnath V; Valentine WM
Toxicol Sci; 2006 Feb; 89(2):485-94. PubMed ID: 16291825
[TBL] [Abstract][Full Text] [Related]
4. Peripheral nerve protein expression and carbonyl content in N,N-diethlydithiocarbamate myelinopathy.
Viquez OM; Valentine HL; Friedman DB; Olson SJ; Valentine WM
Chem Res Toxicol; 2007 Mar; 20(3):370-9. PubMed ID: 17323979
[TBL] [Abstract][Full Text] [Related]
5. Studies on the metabolic activation of disulfiram in rat. Evidence for electrophilic S-oxygenated metabolites as inhibitors of aldehyde dehydrogenase and precursors of urinary N-acetylcysteine conjugates.
Hu P; Jin L; Baillie TA
J Pharmacol Exp Ther; 1997 May; 281(2):611-7. PubMed ID: 9152363
[TBL] [Abstract][Full Text] [Related]
6. Release of carbon disulfide is a contributing mechanism in the axonopathy produced by N,N-diethyldithiocarbamate.
Johnson DJ; Graham DG; Amarnath V; Amarnath K; Valentine WM
Toxicol Appl Pharmacol; 1998 Feb; 148(2):288-96. PubMed ID: 9473537
[TBL] [Abstract][Full Text] [Related]
7. Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy.
Viquez OM; Valentine HL; Amarnath K; Milatovic D; Valentine WM
Toxicol Appl Pharmacol; 2008 May; 229(1):77-85. PubMed ID: 18284930
[TBL] [Abstract][Full Text] [Related]
8. Characterization of S-(N,N-Dialkylaminocarbonyl)cysteine Adducts and Enzyme Inhibition Produced by Thiocarbamate Herbicides in the Rat.
Zimmerman LJ; Valentine HL; Valentine WM
Chem Res Toxicol; 2004 Feb; 17(2):258-67. PubMed ID: 14967014
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacodynamic studies of the disulfiram metabolite S-methyl N,N-diethylthiolcarbamate sulfoxide: inhibition of liver aldehyde dehydrogenase.
Hart BW; Faiman MD
Alcohol Clin Exp Res; 1994 Apr; 18(2):340-5. PubMed ID: 8048736
[TBL] [Abstract][Full Text] [Related]
10. Multicomponent T2 analysis of dithiocarbamate-mediated peripheral nerve demyelination.
Valentine HL; Does MD; Marshall V; Tonkin EG; Valentine WM
Neurotoxicology; 2007 May; 28(3):645-54. PubMed ID: 17350098
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration.
Winefield RD; Heemskerk AA; Kaul S; Williams TD; Caspers MJ; Prisinzano TE; McCance-Katz EF; Lunte CE; Faiman MD
J Pharm Biomed Anal; 2015 Mar; 107():518-25. PubMed ID: 25720821
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram generates a stable N,N-diethylcarbamoyl adduct on Cys-125 of rat hemoglobin beta-chains in vivo.
Erve JC; Jensen ON; Valentine HS; Amarnath V; Valentine WM
Chem Res Toxicol; 2000 Apr; 13(4):237-44. PubMed ID: 10775322
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram produces a non-carbon disulfide-dependent schwannopathy in the rat.
Tonkin EG; Erve JC; Valentine WM
J Neuropathol Exp Neurol; 2000 Sep; 59(9):786-97. PubMed ID: 11005259
[TBL] [Abstract][Full Text] [Related]
14. N,N-diethyldithiocarbamate promotes oxidative stress prior to myelin structural changes and increases myelin copper content.
Viquez OM; Lai B; Ahn JH; Does MD; Valentine HL; Valentine WM
Toxicol Appl Pharmacol; 2009 Aug; 239(1):71-9. PubMed ID: 19467251
[TBL] [Abstract][Full Text] [Related]
15. S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiram.
Mays DC; Nelson AN; Lam-Holt J; Fauq AH; Lipsky JJ
Alcohol Clin Exp Res; 1996 May; 20(3):595-600. PubMed ID: 8727261
[TBL] [Abstract][Full Text] [Related]
16. Protection by disulfiram and diethyldithiocarbamate against hypoxia-induced lethality in mice.
Masukawa T; Nakanishi K
Jpn J Pharmacol; 1993 Nov; 63(3):279-84. PubMed ID: 8107322
[TBL] [Abstract][Full Text] [Related]
17. Diethyldithiocarbamate methyl ester sulfoxide, an inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase and putative metabolite of disulfiram.
Madan A; Faiman MD
Alcohol Clin Exp Res; 1994 Aug; 18(4):1013-7. PubMed ID: 7978080
[TBL] [Abstract][Full Text] [Related]
18. Characterization of diethyldithiocarbamate methyl ester sulfine as an intermediate in the bioactivation of disulfiram.
Madan A; Faiman MD
J Pharmacol Exp Ther; 1995 Feb; 272(2):775-80. PubMed ID: 7853193
[TBL] [Abstract][Full Text] [Related]
19. S-methyl-N,N-diethylthiolcarbamate: a disulfiram metabolite and potent rat liver mitochondrial low Km aldehyde dehydrogenase inhibitor.
Hart BW; Yourick JJ; Faiman MD
Alcohol; 1990; 7(2):165-9. PubMed ID: 2158327
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen substituent polarity influences dithiocarbamate-mediated lipid oxidation, nerve copper accumulation, and myelin injury.
Valentine HL; Viquez OM; Amarnath K; Amarnath V; Zyskowski J; Kassa EN; Valentine WM
Chem Res Toxicol; 2009 Jan; 22(1):218-26. PubMed ID: 19093748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
